Wuxi AppTec’s listing is expected to raise more than 5.7 billion yuan (US$907 million), which will be used to expand its research facilities and build new plants. Photo: Shutterstock Wuxi AppTec’s listing is expected to raise more than 5.7 billion yuan (US$907 million), which will be used to expand its research facilities and build new plants. Photo: Shutterstock
Wuxi AppTec’s listing is expected to raise more than 5.7 billion yuan (US$907 million), which will be used to expand its research facilities and build new plants. Photo: Shutterstock
IPO
Business /  Companies

China fast tracks IPO by leading biotech firm WuXi AppTec, in race as Asia’s hub for fundraising

Mainland’s leading biotech firm privatised in New York two years ago, but has been fast-tracked towards the A-share market just seven weeks after applying to list

Topic |   IPO
Daniel Ren
Daniel Ren

Updated: 10:39am, 28 Mar, 2018

Why you can trust SCMP
Wuxi AppTec’s listing is expected to raise more than 5.7 billion yuan (US$907 million), which will be used to expand its research facilities and build new plants. Photo: Shutterstock Wuxi AppTec’s listing is expected to raise more than 5.7 billion yuan (US$907 million), which will be used to expand its research facilities and build new plants. Photo: Shutterstock
Wuxi AppTec’s listing is expected to raise more than 5.7 billion yuan (US$907 million), which will be used to expand its research facilities and build new plants. Photo: Shutterstock
READ FULL ARTICLE